Small Pharmaceuticals
Market Cap
₹16,954 ₹16,954 Cr.
P/E
101.77
PEG
7.54
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis comes live if test-kit volume scales within existing capacity and assay commercialization supports demand without material tender or customer delays.

The bull path combines faster kit-volume growth with stronger realization; the bear path reflects volume shortfall, weaker pricing, delayed commercialization and underused capacity.

Overview

Shareholder Break-up

Trend

  • 1y
  • 2y
  • 4y
  • 5y
  • 10y
  • Promoter
  • Mutual Funds
  • Insurance Companies
  • FII
  • DII-Others
  • Individual < 2 lac
  • Shares Pledged by Promoters(As a % of Total Promoter Holding)
  • Others

Detailed

FAQs on Molbio Diagnostics Ltd. Shareholdings

There is Insufficient data to gauge this.

There is Insufficient data to gauge this.

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech